Clinical Trial Update: Phase II Study of TAS-109 to Treat Advanced Colorectal Cancer [Phase 2]

View source ↗

Summary

A Phase II study of TAS-109 for advanced colorectal cancer was terminated, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• TAS-109 (TAS-109)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Advanced Colorectal Cancer | Phase 2 | Status: TERMINATED | Results posted: 2011-08-17